Skip to content
Clinical Trials – home

Exploring Morphine in Clinical Trials: Applications, Effectiveness, and Safety Considerations

3 / 6
trials open to patients / all trials
3+
Countries

In short

Morphine is one of the most widely used opioid medications for pain management in medical settings. It plays a critical role in controlling moderate to severe pain associated with various conditions and surgical procedures. This article examines how morphine is being investigated in clinical trials across different medical contexts, from post-surgical pain management to specialized applications in cancer care. By understanding the current research on morphine, patients and healthcare providers can make more informed decisions about pain management strategies while being aware of both benefits and potential concerns.

Key points

  • Morphine remains a cornerstone of pain management across numerous clinical contexts, with ongoing research focusing on optimizing its use. Clinical trials are investigating various administration methods including intravenous, oral, and neuraxial (spinal/epidural) routes for post-surgical pain, acute emergencies, and chronic conditions. Researchers are comparing morphine to alternatives like ketamine and fentanyl, while also developing novel formulations with extended-release properties and abuse-deterrent features. Special attention is being given to vulnerable populations such as children, elderly patients, and those with sleep apnea. While morphine effectively controls moderate to severe pain, trials are carefully monitoring side effects including respiratory depression, nausea, and sedation to improve the balance between pain relief and patient safety.

Introduction to Morphine

Morphine is a potent opioid medication primarily used for the treatment of moderate to severe pain. It belongs to a class of drugs known as opioid analgesics, which work by binding to opioid receptors in the brain and spinal cord to reduce the sensation of pain. Morphine is considered one of the standard treatments for severe pain management in both acute and chronic settings .

Morphine is also known by several brand names, including MST Continus, KADIAN, MorphaBond ER, and Duramorph. The medication is available in various formulations, including immediate-release (IR) and extended-release (ER) forms, allowing for different durations of pain relief .

Medical Uses of Morphine

Morphine is primarily used to treat various types of pain, including:

  • Post-surgical pain: Morphine is commonly used for pain management after surgeries such as cesarean sections, laparoscopic procedures, and thoracotomies .
  • Cancer-related pain: It is effective for controlling pain in patients with cancer .
  • Acute pain: Conditions such as renal colic, abdominal pain, and musculoskeletal pain may be treated with morphine when other pain medications are insufficient .
  • Chronic non-cancer pain: In some cases, morphine may be prescribed for long-term management of severe chronic pain, such as that from osteoarthritis .

Methods of Administration

Morphine can be administered through various routes, each with different onset times and durations of action:

  • Intravenous (IV): Direct injection into a vein provides the fastest onset of action (within minutes) and is commonly used in hospital settings for acute pain management .
  • Oral: Available as tablets, capsules, or liquid, oral morphine has a slower onset but is convenient for outpatient use. Extended-release formulations (like MorphaBond ER or KADIAN) can provide pain relief for up to 24 hours .
  • Intrathecal/Epidural: Injection into the spinal fluid (intrathecal) or space around the spinal cord (epidural) provides targeted pain relief with lower doses. This method is often used for post-surgical pain management and during childbirth .
  • Patient-Controlled Analgesia (PCA): A system that allows patients to self-administer small doses of morphine when needed, within predetermined safety limits .

Effectiveness for Pain Management

Morphine is highly effective for managing moderate to severe pain. Clinical studies have consistently shown its efficacy in various pain conditions:

  • Post-surgical pain: Studies have demonstrated that morphine significantly reduces pain scores following surgical procedures. For example, in laparoscopic sigmoidectomy, morphine PCA (Patient-Controlled Analgesia) effectively controlled postoperative pain as measured by EVA (postoperative pain) scales .
  • Acute pain in emergency settings: In emergency departments, morphine is effective for controlling severe acute pain from conditions such as renal colic, abdominal pain, and back pain .
  • Chronic pain: Extended-release morphine formulations have shown effectiveness for long-term pain management, with studies reporting improved pain scores over 12-week periods in patients with conditions like osteoarthritis .

Pain relief typically begins within 15-60 minutes of oral administration and within minutes when given intravenously. The duration of effect varies depending on the formulation, ranging from 4-6 hours for immediate-release forms to 12-24 hours for extended-release versions .

Comparisons with Other Pain Medications

Morphine has been compared to various other pain medications in clinical trials:

  • Morphine vs. Ketamine: A randomized controlled trial comparing low-dose ketamine to morphine for acute pain control in the emergency department found both medications effective, but with different side effect profiles. Ketamine may cause more agitation, while morphine is more likely to cause respiratory depression .
  • Morphine vs. Methadone: In a study of patients undergoing laparoscopic cholecystectomy, methadone showed comparable analgesic effects to morphine but with a longer duration of action. Both medications improved quality of recovery scores, but methadone required less frequent dosing .
  • Morphine vs. Remifentanil combination: The combination of remifentanil and morphine for post-thoracotomy pain showed improved pain control compared to morphine alone, suggesting potential benefits of combining different opioids in certain settings .
  • Morphine vs. Regional anesthesia: Studies comparing morphine to techniques like caudal bupivacaine or pericapsular nerve group (PENG) blocks show that regional anesthesia may provide comparable or better pain relief with fewer systemic side effects in specific surgical scenarios .

Side Effects and Safety Concerns

Morphine can cause various side effects, ranging from common and mild to rare but serious:

Common side effects include:

  • Nausea and vomiting: These are among the most common side effects, affecting many patients who receive morphine .
  • Constipation: Opioids slow intestinal motility, leading to constipation in most patients using morphine regularly .
  • Drowsiness and sedation: Morphine can cause sleepiness, especially when treatment is first started or dosage is increased .
  • Itching: Particularly common with intrathecal (spinal) administration .

More serious side effects include:

  • Respiratory depression: Slowed or shallow breathing is the most dangerous side effect and requires immediate medical attention .
  • Hypotension: Morphine can cause blood pressure to drop, especially when changing positions .
  • Urinary retention: Difficulty urinating may occur, particularly in older male patients .

Long-term concerns:

  • Tolerance: Over time, higher doses may be needed to achieve the same pain relief .
  • Physical dependence: The body becomes accustomed to the medication, leading to withdrawal symptoms if suddenly stopped .
  • Risk of addiction: There is potential for psychological dependence and addiction, though this risk is often overstated in patients using morphine appropriately for pain .

Special Populations

Pediatric patients: Morphine can be used in children, but dosing must be carefully adjusted based on weight and age. Specialized pain assessment tools like the CRIES (Crying, Requires oxygen, Increased vital signs, Expression, Sleeplessness) for neonates and FLACC (Face, Legs, Activity, Cry, Consolability) for older infants are used to evaluate pain and morphine effectiveness .

Elderly patients: Older adults may be more sensitive to the effects of morphine and typically require lower doses. They are also at increased risk for side effects like confusion, constipation, and respiratory depression .

Pregnant and breastfeeding women: Morphine crosses the placenta and can be used in pregnancy when the benefits outweigh the risks. It's commonly used for pain management during labor and after cesarean sections. Low doses in breastfeeding mothers are generally considered acceptable, but infants should be monitored for sedation .

Patients with obstructive sleep apnea: Caution is needed as morphine can worsen sleep-disordered breathing. Research has examined the effects of intravenous morphine on patients with moderate obstructive sleep apnea, showing the importance of careful monitoring in this population .

How Morphine Works in the Body

Understanding how morphine is processed in the body can help patients better comprehend its effects and limitations:

  • Absorption: When taken orally, morphine undergoes significant first-pass metabolism in the liver, resulting in lower bioavailability (about 30-40%) compared to intravenous administration. Food can affect the absorption of some morphine formulations .
  • Distribution: Once in the bloodstream, morphine is distributed throughout the body, including to the brain where it exerts its pain-relieving effects. It crosses the blood-brain barrier, though not as efficiently as some other opioids .
  • Metabolism: Morphine is primarily metabolized in the liver through a process called glucuronidation, primarily by the enzyme UGT2B7. It forms two main metabolites: morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Interestingly, M6G is actually more potent as a pain reliever than morphine itself .
  • Elimination: Morphine and its metabolites are primarily eliminated through the kidneys. The half-life of morphine is approximately 2-4 hours, meaning it takes this long for half of the drug to be eliminated from the body .

Individual genetic differences can affect how morphine is metabolized. Research has shown that variations in genes like CYP2D6 and UGT2B7 can influence how effectively morphine works and how likely someone is to experience side effects .

Understanding these factors helps explain why morphine may work differently in different people and why dosages often need to be individualized for optimal pain control with minimal side effects.

Questions people often ask

Conditions where MORPHINE is being studied

Each condition opens its own overview and trial list

Trials with MORPHINE

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.